Life Sciences Archives

NextGen Now: Delivering tomorrow’s facilities today

If cell and gene therapy products are to successfully reach patients and deliver transformative cures, then the industry will need more facilities capable of manufacturing them.

An artistic portrayal of adeno-associated viral vectors used in gene therapy manufacture

Advanced therapy medicinal product facilities through the eyes of a process architect

Advanced therapy medicinal product (ATMP) companies are ushering in a new frontier of medicine and technologies poised to revolutionize human health, but are ATMP facilities keeping up? The industry is advancing at such a rapid pace that these companies are faced with vast new complexities when developing and manufacturing their products.

A large chiller outside, which could be made more efficient with an ice storage system

How biopharma facilities can use ice in a glycol chiller system

Ice storage, coupled with a glycol chiller, can provide benefits that other options can’t.

Oral solid dose tablets on a continuous manufacturing line

Continuous OSD manufacturing—a technology update

Continuous oral solid dosage manufacturing is a transformational processing platform that is here today and is here to stay. Although the industry is working on harmonization and some level of standardization of the platforms, continuous manufacturing is not a one-size-fits all offering.

Closing the deal: Understanding when to close your process

When to close your pharmaceutical process

Too often, the term “closed process” is thrown around without an understanding of the salient issues. Pharmaceutical process closure can certainly provide many benefits, but there are various impacts and requirements depending on the ultimate goal and the specific process you are trying to close.

Can’t hack it? Why pharma should heed the growing threats to cyber security

Cybersecurity considerations for pharmaceutical companies

Who would want to hack a programmable logic controller? Is cybersecurity really that important for pharma companies?

Continuous OSD manufacturing and patient impact

FDA approved oral solid dosage (OSD) products are improving, changing and enhancing lives, via the use of a continuous manufacturing platform.

Passing through the barrier

Over the past decade, aseptic filling isolators have improved patient safety by use of barriers to isolate the point of filling from personnel. This industry-wide movement creates opportunities to further increase patient safety by minimizing viable and nonviable risks to the aseptic fill.

Common pitfalls to avoid with building a lab

Building a lab: 7 common pitfalls to avoid

Building a lab can be complicated. To stay competitive, it is crucial that companies adapt to market changes. New products and services may mean changes in operations. For companies that have lab spaces, this can be costly. Many companies make decisions based on saving money without planning ahead.

To outsource or not to outsource? That is the question: How to ensure your CMO stacks up

How to choose a contract manufacturing organization

The age-old debate of whether to outsource production to a contract manufacturing organization (CMO) remains for mature, emerging and virtual biopharmaceutical companies.